Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations.

Fanale D, Iovanna JL, Calvo EL, Berthezene P, Belleau P, Dagorn JC, Ancona C, Catania G, D'Alia P, Galvano A, Gulotta E, Lo Dico S, Passiglia F, Bronte G, Midiri M, Lo Re G, Cicero G, Bazan V, Russo A.

Oncology. 2013;85(5):306-11. doi: 10.1159/000354737. Epub 2013 Nov 9.

PMID:
24217364
2.

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

Fanale D, Iovanna JL, Calvo EL, Berthezene P, Belleau P, Dagorn JC, Bronte G, Cicero G, Bazan V, Rolfo C, Santini D, Russo A.

Expert Opin Ther Targets. 2014 Aug;18(8):841-50. doi: 10.1517/14728222.2014.920324. Epub 2014 May 16.

PMID:
24834797
3.

Identification of germline genomic copy number variation in familial pancreatic cancer.

Al-Sukhni W, Joe S, Lionel AC, Zwingerman N, Zogopoulos G, Marshall CR, Borgida A, Holter S, Gropper A, Moore S, Bondy M, Klein AP, Petersen GM, Rabe KG, Schwartz AG, Syngal S, Scherer SW, Gallinger S.

Hum Genet. 2012 Sep;131(9):1481-94. doi: 10.1007/s00439-012-1183-1. Epub 2012 Jun 5.

4.

Germline copy number variations in BRCA1-associated ovarian cancer patients.

Yoshihara K, Tajima A, Adachi S, Quan J, Sekine M, Kase H, Yahata T, Inoue I, Tanaka K.

Genes Chromosomes Cancer. 2011 Mar;50(3):167-77. doi: 10.1002/gcc.20841. Epub 2010 Dec 7.

PMID:
21213370
5.

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.

Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S.

Genes Chromosomes Cancer. 2000 Apr;27(4):358-61.

PMID:
10719365
6.

BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.

Cho JH, Bang S, Park SW, Chung JB, Song SY.

Pancreas. 2008 May;36(4):337-40. doi: 10.1097/MPA.0b013e31815c75ea.

PMID:
18437078
7.

Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer.

Matsubayashi H, Fukushima N, Sato N, Brune K, Canto M, Yeo CJ, Hruban RH, Kern SE, Goggins M.

Cancer Biol Ther. 2003 Nov-Dec;2(6):652-5.

PMID:
14688470
8.

Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome.

Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, Falda A, Pizzi S, Parenti A, Pedrazzoli S, Plebani M.

Am J Clin Pathol. 2006 Oct;126(4):593-601.

PMID:
16938655
9.

Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.

Martin ST, Matsubayashi H, Rogers CD, Philips J, Couch FJ, Brune K, Yeo CJ, Kern SE, Hruban RH, Goggins M.

Oncogene. 2005 May 19;24(22):3652-6.

PMID:
15806175
10.

Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.

Pierce BL, Austin MA, Ahsan H.

Cancer Causes Control. 2011 Jun;22(6):877-83. doi: 10.1007/s10552-011-9760-5. Epub 2011 Mar 29.

PMID:
21445555
11.

The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.

Legoffic A, Calvo E, Cano C, Folch-Puy E, Barthet M, Delpero JR, Ferrés-Masó M, Dagorn JC, Closa D, Iovanna J.

PLoS One. 2009 Oct 16;4(10):e7495. doi: 10.1371/journal.pone.0007495.

12.

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE.

Cancer Res. 1996 Dec 1;56(23):5360-4.

13.

Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.

Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Lin M, Lee C, Wong WH, Rao PH, Lau CC, Berkowitz RS, Wong KK, Mok SC.

Cancer Genet Cytogenet. 2004 Dec;155(2):97-107.

PMID:
15571795
14.

His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.

Ohnami S, Sato Y, Yoshimura K, Ohnami S, Sakamoto H, Aoki K, Ueno H, Ikeda M, Morizane C, Shimada K, Sakamoto Y, Esaki M, Saito I, Hirose H, Saito D, Sugimura H, Kosuge T, Okusaka T, Yoshida T.

Gastroenterology. 2008 Aug;135(2):477-88. doi: 10.1053/j.gastro.2008.04.016. Epub 2008 Apr 18.

PMID:
18515090
15.

Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arrays.

Ha G, Shah S.

Methods Mol Biol. 2013;973:355-72. doi: 10.1007/978-1-62703-281-0_22.

PMID:
23412801
16.

Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.

Dergham ST, Dugan MC, Arlauskas P, Du W, Vaitkevicius VK, Crissman JD, Sarkar FH.

Int J Pancreatol. 1997 Jun;21(3):225-34.

PMID:
9322121
17.

Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.

Duell EJ, Casella DP, Burk RD, Kelsey KT, Holly EA.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):726-31.

18.

Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays.

Komura D, Shen F, Ishikawa S, Fitch KR, Chen W, Zhang J, Liu G, Ihara S, Nakamura H, Hurles ME, Lee C, Scherer SW, Jones KW, Shapero MH, Huang J, Aburatani H.

Genome Res. 2006 Dec;16(12):1575-84. Epub 2006 Nov 22.

19.

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.

Ghiorzo P, Fornarini G, Sciallero S, Battistuzzi L, Belli F, Bernard L, Bonelli L, Borgonovo G, Bruno W, De Cian F, Decensi A, Filauro M, Faravelli F, Gozza A, Gargiulo S, Mariette F, Nasti S, Pastorino L, Queirolo P, Savarino V, Varesco L, Scarrà GB; Genoa Pancreatic Cancer Study Group.

J Med Genet. 2012 Mar;49(3):164-70. doi: 10.1136/jmedgenet-2011-100281.

PMID:
22368299
20.

A new platform for gene discovery in pancreatic cancer.

Callery MP.

Gastroenterology. 2005 Aug;129(2):763-4. No abstract available.

PMID:
16083736

Supplemental Content

Support Center